Achieve Life Sciences Inc (ACHV-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr03/2024	Next Qtr06/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	-0.24	-0.22	-0.94	-0.88
Number of Estimates	1	1	3	2
High Estimate	-0.24	-0.22	-0.85	-0.83
Low Estimate	-0.24	-0.22	-1.07	-0.93
Prior Year	-0.50	-0.43	-1.50	-0.94
Growth Rate Est. (year over year)	+52.00%	+48.84%	+37.33%	+6.38%

Earnings History - Surprises*

	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023	Qtr Ending03/2023
Reported	$-0.26	$-0.34	$-0.43	$-0.50
Estimate	$-0.32	$-0.34	$-0.41	$-0.65
Difference	+0.06	unch	-0.02	+0.15
Surprise	+18.75%	unch	-4.88%	+23.08%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

5.00

3 Mths Ago4

5.00

2 Mths Ago4

5.00

1 Mth Ago4

5.00

Current4

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	4	4	4	4
	4	4	4	4
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

At midday: TSX struggles for direction as investors prepare for U.S. Fed decision

The close: Major North American indexes rise as megacap tech stocks rally

Why this money manager is venturing back into emerging markets and adding more U.S. tech

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders

The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market

Fiera Capital’s largest shareholder looks to sell stake in company

The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide